StephenMStahlMD

Psychiatry • Carlsbad, CA

Psychopharmacology

Adjunct Professor of Psychiatry University of California San Diego

Join to view full profile

Dr. Stahl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Stahl's full profile

Already have an account?

Office
1930 Palomar Point Way
Ste 103
Carlsbad, CA 92008
Phone+1 760-444-9065

Fax+1 760-931-8857

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Psychiatry, 1979 - 1981
University of California (San Francisco)Residency, Neurology, 1977 - 1978
University of ChicagoInternship, Internal Medicine, 1976 - 1977
Northwestern University The Feinberg School of MedicineClass of 1974

Certifications & Licensure

OH State Medical License 1975 - 2026
CA State Medical License 1977 - 2025
IN State Medical License 1975 - 2025
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

71 citations
Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
John Zajecka, Alan F. Schatzberg, Stephen M. Stahl, Amy Shah, Angelika Caputo
Journal of Clinical Psychopharmacology. 2010-04-01
349 citations
A novel augmentation strategy for treating resistant major depression.
Richard C. Shelton, G.D. Tollefson, Mauricio Tohen, Stephen M. Stahl, Kimberley S. Gannon
The American Journal of Psychiatry. 2001-01-01
98 citations
Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression
Stephen M. Stahl, Richard Entsuah, Richard Leslie Rudolph
Biological Psychiatry. 2002-12-15

Lectures

NEI Clinical Update: MAOIs Course Two: A Mentorship on the Use of MAOIs
Neuroscience Education Institute, Huntington Beach, California - 9/15/2012
2011 NEI Global Psychopharmacology Congress
Neuroscience Education Institute, Colorado Springs, Colorado - 11/10/2011

Press Mentions

Genomind Mental Health Map: First-Ever Consumer DNA Test to Unlock the Connection Between Genetics and Mental Wellness-Related Behavioral Tendencies, Offers “How-To” Guidance to Improve Mental Health and WellnessJune 24th, 2020
Researchers Present New Data on the Utility of Genomind's Mental Health Pharmacogenomic Testing at Upcoming Scientific ConferencesSeptember 16th, 2019
FDA Expands Use of Cariprazine to Include Treatment of Depressive EpisodesMay 28th, 2019
Join now to see all